The authors reply

New England Journal of Medicine

Volumn 364, Issue 10, 2011, Pages 979-

  Wong, Tien Y ^a   Scott, Ingrid U ^b  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; VASCULOTROPIN ANTIBODY;

DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; LOW LEVEL LASER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA VEIN OCCLUSION;

EID: 84863645087     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1014381     Document Type: Letter

References (4)

1. Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 2010;103:271-6.
2. Lazo-Langner A, Hawel J, Ageno W, Kovacs MJ. Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica 2010;95:1587-93.
3. McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:835-54.
4. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:507-19. (Pubitemid 46282974)